MwanzoHALO • NASDAQ
add
Halozyme Therapeutics, Inc.
Bei iliyotangulia
$ 61.06
Bei za siku
$ 61.11 - $ 62.56
Bei za mwaka
$ 37.73 - $ 65.53
Thamani ya kampuni katika soko
7.85B USD
Wastani wa hisa zilizouzwa
1.28M
Uwiano wa bei na mapato
18.21
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 298.01M | 29.55% |
Matumizi ya uendeshaji wa biashara | 60.01M | 8.38% |
Mapato halisi | 137.01M | 60.46% |
Kiwango cha faida halisi | 45.98 | 23.87% |
Mapato kwa kila hisa | 1.26 | 53.66% |
EBITDA | 194.52M | 61.52% |
Asilimia ya kodi ya mapato | 23.12% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 596.07M | 77.40% |
Jumla ya mali | 2.06B | 19.05% |
Jumla ya dhima | 1.70B | 3.04% |
Jumla ya hisa | 363.82M | — |
hisa zilizosalia | 123.15M | — |
Uwiano wa bei na thamani | 20.70 | — |
Faida inayotokana na mali | 20.99% | — |
Faida inayotokana mtaji | 22.57% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 137.01M | 60.46% |
Pesa kutokana na shughuli | 178.47M | 74.36% |
Pesa kutokana na uwekezaji | 29.48M | 455.57% |
Pesa kutokana na ufadhili | -246.42M | 1.40% |
Mabadiliko halisi ya pesa taslimu | -38.47M | 75.32% |
Mtiririko huru wa pesa | 132.16M | 73.85% |
Kuhusu
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1998
Makao Makuu
Tovuti
Wafanyakazi
350
